Stay updated on ENABLE Study: Lanadelumab in HAE Clinical Trial
Sign up to get notified when there's something new on the ENABLE Study: Lanadelumab in HAE Clinical Trial page.

Latest updates to the ENABLE Study: Lanadelumab in HAE Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedRevision: v3.3.3 was added to the record history, and the footer now omits 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2'; these are minor site-maintenance updates that do not affect study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check38 days agoChange DetectedThe Study Record Versions now show a new Revision: v3.3.2 and the removal of Revision: v3.2.0.SummaryDifference0.1%

- Check45 days agoChange DetectedDeleted the government funding and operating status notice directing users to cc.nih.gov and opm.gov.SummaryDifference0.7%

- Check59 days agoChange Detected- Added a new version entry dated 2025-08-29 to the Record History, reflecting updated study status and related sections.SummaryDifference0.1%

- Check88 days agoChange DetectedSummary: The page adds a government-operating-status notice and a v3.2.0 release tag, while removing the v3.1.0 tag. The new notice is the significant change, signaling updated operating status and potential transaction delays.SummaryDifference12%

- Check95 days agoChange DetectedUpdated the page from revision v3.0.2 to v3.1.0, signaling a new release version.SummaryDifference0.3%

Stay in the know with updates to ENABLE Study: Lanadelumab in HAE Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ENABLE Study: Lanadelumab in HAE Clinical Trial page.